← All candidates
250 insider filings on record.
250 filings on record.
PTCTPTC THERAPEUTICS, INC.
NasdaqGS · Healthcare · $5.47B
$65.65
-1.25% · Sep 15
250 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 172 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$5.47B
Float
73.7M
88% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
24.5
Price / sales
5.4
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
245 more transactions on Pro →Context
Wall St
$94.14 avg target
+43.4% vs today · 14 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.03 act+$0.41
Q4 '25−$1.80 act−$1.39
Q3 '25$0.19 act+$1.30
Q2 '25−$0.83 act+$0.23
Coverage
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMNZacks · 07-10PTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should KnowZacks · 07-08PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?Zacks · 06-18Why The PTC Therapeutics (PTCT) Story Is Shifting As Sephience Assumptions Drive New ValuationsSimply Wall St. · 06-07
The file stays open
250 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice